Skip to content

Clinical trials

Terminated Phase 3 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Status: Terminated Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20024
20033
20046
20057
20065
20074
20083
20097
20103
20126
20132
20143
20151
20163
20173
20182
20193
20205
20216
20225

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated90

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
ETOP IBCSG Partners Foundation3
Hoffmann-La Roche3
Intarcia Therapeutics3
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
SWOG Cancer Research Network3
Spanish Breast Cancer Research Group3
European Organisation for Research and Treatment of Cancer - EORTC2
GBG Forschungs GmbH2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms90
Neoplasm Metastasis7
Pain4
Brain Neoplasms3
Lung Neoplasms3
Blast Crisis2
Burkitt Lymphoma2
Carcinoma, Ductal, Breast2
Carcinoma, Lobular2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.